G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text
Team | IMMEI
PDF) G-quadruplexes: a promising target for cancer therapy
Team | IMMEI
Team | IMMEI
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Erfolg bei Ausschreibung? Advanced Clinician Scientist? – Forschende Mediziner erhalten Förderung durch das BMBF - MINQ Magazin
Liebe Leserin, lieber Leser,
ImmunoSensation / The Immune Sensory System » Details
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
UKB NewsRoom | Annkristin Heine
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
ImmunoSensation / The Immune Sensory System » Details
Caspase-3 activity is increased significantly upon treatment with Syk... | Download Scientific Diagram
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Café Kinderwagen: ein Angebot für Groß und Klein | Spökenkieker - Ihr regionales Anzeigenmagazin
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Loop | Annkristin Heine
Team | IMMEI
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Implementing combinatorial immunotherapeutic regimens against cancer
